Inhibition of replication of human respiratory syncytial virus by 6-diazo-5-oxo-l-norleucine
- 31 December 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 25 (3) , 269-279
- https://doi.org/10.1016/0166-3542(94)90009-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomasInvestigational New Drugs, 1990
- Antiviral Effect of 6-diazo-5-oxo-L-Norleucine, Antagonist of -glutamyl Transpeptidase, on Replication of Human Parainfluenza Virus Type 2Journal of General Virology, 1990
- Ribavirin: A clinical overviewEuropean Journal of Epidemiology, 1986
- Characterization of the 10 proteins of human respiratory syncytial virus: Identification of a fourth envelope-associated proteinVirus Research, 1985
- Poliovirus and vesicular stomatitis virus replication in the presence of 6-diazo-5-oxo-L-norleucine or 2-deoxy-D-glucoseJournal of Medical Virology, 1984
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Ribavirin Treatment of Experimental Respiratory Syncytial Viral InfectionPublished by American Medical Association (AMA) ,1983
- Inhibition of palatal epithelial cell death by altered protein synthesisDevelopmental Biology, 1976
- Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by InfectionPediatric Research, 1976